Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BioMix Hälso AB
AB
Active
Org 5591495725
Sjöholmsvägen 63
Physiotherapy activities · NACE 8695
Est. 2018
1-4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 358K
+29% vs 2023
EBITDA margin
23.9%
+16645% vs 2023
Equity ratio
62.5%
Financial strength
Net profit 2024
SEK 66K
+8594% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 358K
+29%
EBITDA
SEK 85K
+16645%
Net profit
SEK 66K
+8594%
Total assets
SEK 446K
+39%
Equity
SEK 279K
+31%
Employees
—
—
Company information
Legal name
BioMix Hälso AB
Org number
5591495725
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
16 februari 2018
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska naprapatbehandlingar, medicinsk termografi, alternativ mammografi och massage samt inom alla angivna områden förenlig verksamhet.
Contact
Address
Sjöholmsvägen 63
Email
info@thermografi.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Physiotherapy activities
Companies in Haninge
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
217
233
329
278
358
Staff expenses
—
—
−186
−185
−159
EBITDA
99
−21
37
1
85
Depreciation & amort.
−10
−10
−10
—
−3
EBIT
89
−31
27
1
83
Net financials
—
—
−0
0
0
Profit before tax
89
−31
27
1
83
Tax
−19
−0
—
—
−17
Net profit
70
−31
27
1
66
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
290
337
355
320
446
Equity
216
185
212
213
279
Long-term debt
31
101
86
88
75
Short-term debt
42
51
57
20
92
Total debt
73
152
143
107
167
Financial ratios
5-year trend
EBITDA margin
23.9%
This company
15.8%
Market median
+51% vs market
2020
2024
Equity ratio
62.5%
This company
38.2%
Market median
+64% vs market
2020
2024
Return on equity
23.8%
This company
18.4%
Market median
+29% vs market
2020
2024
Net profit margin
18.5%
This company
8.1%
Market median
+128% vs market
2020
2024
Asset turnover
0.80×
This company
1.12×
Market median
-29% vs market
2020
2024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
NI
Nils Ingemar Thid
Board of Directors
2022
NP
Nils Peter Thid
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BioMix Hälso AB also hold positions in
0
other companies.
Person
Role here
Other companies
Nils Ingemar Thid
Board of Directors
0 companies
Nils Peter Thid
Deputy Board Member
0 companies